SWI019

· Calibr, a division of Scripps Research

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SWI019, covering 2024-08-20 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases [Phase 1]